Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avik Roy

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Cell Metabolism|June 30, 2015
HMG-CoA Reductase Inhibitors Bind to PPARα to Upregulate Neurotrophin Expression in the Brain and Improve Memory in MiceAvik Roy, Malabendu Jana, Madhuchhanda Kundu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
IL-12 p40 monomer is different from other IL-12 family members to selectively inhibit IL-12Rβ1 internalization and suppress EAESusanta Mondal, Madhuchhanda Kundu, Malabendu Jana, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2007
Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's diseaseAnamitra Ghosh, Avik Roy, Xiaojuan Liu, et al.
Cells|December 17, 2024
JRM-28, a Novel HDAC2 Inhibitor, Upregulates Plasticity-Associated Proteins in Hippocampal Neurons and Enhances Morphological Plasticity via Activation of CREB: Implications for Alzheimer's DiseaseA F M Towheedur Rahman, Sarojini Bulbule, Jawad Bin Belayet, et al.
Research Square|June 12, 2025
Low Dose Rapamycin Alleviates Clinical Symptoms of Fatigue and PEM in ME/CFS Patients via Improvement of AutophagyBrian T Ruan, Sarojini Bulbule, Amy Reyes, et al.
The Journal of Clinical Investigation|July 11, 2018
Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer's pathologySuresh B Rangasamy, Malabendu Jana, Avik Roy, et al.
Journal of Translational Medicine|October 22, 2025
Low-dose rapamycin alleviates clinical symptoms of fatigue and PEM in ME/CFS patients via improvement of autophagy: a pilot studyBrian T Ruan, Sarojini Bulbule, Brooke Gile, et al.
Neurobiology of Disease|December 24, 2018
Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's diseaseHemraj B Dodiya, Christopher B Forsyth, Robin M Voigt, et al.
Journal of Translational Medicine|July 10, 2026
Association of rapamycin treatment with the modulation of purine metabolism, reduced microglial inflammatory responses, improved mitochondrial energy metabolism, and alleviation of fatigue symptoms in ME/CFS subjects: pilot findings from phase-II observational studyBrooke Gile, Sarojini Bulbule, Mubaraq A Toriola, et al.
Redox Biology|June 9, 2026
Exploiting vitamin C as a prooxidant to activate ROS-responsive prodrugs for potent and selective tumor killingTaufeeque Ali, Thilini Nimasha Fernando Ponnamperumage, Cody Joshua Miller, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Cell Metabolism|June 30, 2015
HMG-CoA Reductase Inhibitors Bind to PPARα to Upregulate Neurotrophin Expression in the Brain and Improve Memory in MiceAvik Roy, Malabendu Jana, Madhuchhanda Kundu, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2020
IL-12 p40 monomer is different from other IL-12 family members to selectively inhibit IL-12Rβ1 internalization and suppress EAESusanta Mondal, Madhuchhanda Kundu, Malabendu Jana, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2007
Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's diseaseAnamitra Ghosh, Avik Roy, Xiaojuan Liu, et al.
Cells|December 17, 2024
JRM-28, a Novel HDAC2 Inhibitor, Upregulates Plasticity-Associated Proteins in Hippocampal Neurons and Enhances Morphological Plasticity via Activation of CREB: Implications for Alzheimer's DiseaseA F M Towheedur Rahman, Sarojini Bulbule, Jawad Bin Belayet, et al.
Research Square|June 12, 2025
Low Dose Rapamycin Alleviates Clinical Symptoms of Fatigue and PEM in ME/CFS Patients via Improvement of AutophagyBrian T Ruan, Sarojini Bulbule, Amy Reyes, et al.
The Journal of Clinical Investigation|July 11, 2018
Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer's pathologySuresh B Rangasamy, Malabendu Jana, Avik Roy, et al.
Journal of Translational Medicine|October 22, 2025
Low-dose rapamycin alleviates clinical symptoms of fatigue and PEM in ME/CFS patients via improvement of autophagy: a pilot studyBrian T Ruan, Sarojini Bulbule, Brooke Gile, et al.
Neurobiology of Disease|December 24, 2018
Chronic stress-induced gut dysfunction exacerbates Parkinson's disease phenotype and pathology in a rotenone-induced mouse model of Parkinson's diseaseHemraj B Dodiya, Christopher B Forsyth, Robin M Voigt, et al.
Journal of Translational Medicine|July 10, 2026
Association of rapamycin treatment with the modulation of purine metabolism, reduced microglial inflammatory responses, improved mitochondrial energy metabolism, and alleviation of fatigue symptoms in ME/CFS subjects: pilot findings from phase-II observational studyBrooke Gile, Sarojini Bulbule, Mubaraq A Toriola, et al.
Redox Biology|June 9, 2026
Exploiting vitamin C as a prooxidant to activate ROS-responsive prodrugs for potent and selective tumor killingTaufeeque Ali, Thilini Nimasha Fernando Ponnamperumage, Cody Joshua Miller, et al.
Pageof 8